Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001179110-20-000546

Director acquired 60,186 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

JEFFS ROGER · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-01-10 Exercise or conversion : show line 1 in the form +9,127 $9.00 $82,143 65,747 D
2020-01-10 Exercise or conversion : show line 2 in the form +5,193 $8.02 $41,648 70,940 D
2020-01-10 Exercise or conversion : show line 3 in the form +11,000 $4.95 $54,450 81,940 D
2020-01-10 Exercise or conversion : show line 4 in the form +34,866 $12.95 $451,515 116,806 D

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2020-01-10 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −9,127 0 D
2020-01-10 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −5,193 0 D
2020-01-10 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −11,000 0 D
2020-01-10 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −34,866 0 D
Loading xslF345X03/edgar.xml…